FOCAL SEIZURE
Clinical trials for FOCAL SEIZURE explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEIZURE trials appear
Sign up with your email to follow new studies for FOCAL SEIZURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could cut seizures in half for epilepsy patients
Disease control Recruiting nowThis study tests an experimental drug, RAP-219, in 333 adults with focal seizures (a type of epilepsy). Participants will take the drug or a placebo for several weeks to see if it safely reduces how often seizures happen. The goal is to find a new treatment option for people whos…
Matched conditions: FOCAL SEIZURE
Phase: PHASE3 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 02:27 UTC
-
New hope for tough seizures: RAP-219 safety trial opens
Disease control Recruiting nowThis study tests the long-term safety of an experimental drug called RAP-219 in 30 adults with refractory focal epilepsy—seizures that don't respond well to current treatments. Participants must have completed a prior RAP-219 study. The main goal is to track side effects, while a…
Matched conditions: FOCAL SEIZURE
Phase: PHASE2 • Sponsor: Rapport Therapeutics Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC